<DOC>
	<DOCNO>NCT02125227</DOCNO>
	<brief_summary>The objective study Compare Safety Pharmacokinetic Characteristics Co-administration Rosuvastatin Metformin SR YH14755 Investigate Effect Food Pharmacokinetics YH14755 healthy volunteer .</brief_summary>
	<brief_title>Phase 1 Clinical Trial Investigate Effect Pharmacokinetics YH14755 Compared Co-administration Rosuvastatin Metformin SR Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Metformin</mesh_term>
	<mesh_term>Rosuvastatin Calcium</mesh_term>
	<criteria>1 . Healthy male female body mass index ( BMI ) 18.5 25 kg/m2 2. Who suffer clinically significant disease 3 . Provision sign write informed consent 1 . History clinically significant disease 2 . A history drug abuse presence positive reaction drug abuse potential urine screening drug . 3 . Administration investigational product within 3 month prior first dose . 4 . Administration herbal medicine within 4 week administration ethical drug within 2 week administration overthecounter ( OTC ) drug within 1 week prior first dose investigational product ( investigator ( study doctor ) determine person meet criteria appropriately , relevant person may participate study ) . 5 . Volunteers consider eligible clinical trial investigator ( study doctor ) due reason include laboratory test result , ECGs , vital sign .</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>October 2014</verification_date>
</DOC>